Influenza Peter CramSusan G. BlitzA. Mark Fendrick Leading Article 21 September 2012 Pages: 223 - 230
Workplace Productivity Paul StangRoger CadyLynn Hoffman Review Article 21 September 2012 Pages: 231 - 244
Economic Burden of Chronic Obstructive Pulmonary Disease Mitchell FriedmanDaniel E. Hilleman Review Article 21 September 2012 Pages: 245 - 254
Cost Effectiveness of Emedastine versus Levocabastine in the Treatment of Allergic Conjunctivitis in 7 European Countries Carlos Gouveia PintoAntoine LafumaGilles Berdeaux Original Research Article 21 September 2012 Pages: 255 - 265
Cost of Treatment for Onychomycosis David M. StierCurt HenkeJeanette Broering Original Research Article 21 September 2012 Pages: 267 - 279
Cost-Benefit Analysis of Active Vaccination Campaigns Against Hepatitis A Among Daycare Centre Personnel in Israel Gabriel ChodickYehuda LermanShai Ashkenazi Original Research Article 21 September 2012 Pages: 281 - 291
Cost-Effectiveness Analysis of Inhaled Zanamivir in the Treatment of Influenza A and B in High-Risk Patients Adrian D. GriffinAndrew S. PerryDouglas M. Fleming Original Research Article 21 September 2012 Pages: 293 - 301
Rivastigmine Harriet M. LambKaren L. Goa Adis Pharmacoeconomic Drug Evaluation 21 September 2012 Pages: 303 - 318